Suppr超能文献

中国城市 COPD 患者的生活质量及其与直接医疗费用的相关性。

Quality of life and its association with direct medical costs for COPD in urban China.

机构信息

School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, 200032, China.

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

出版信息

Health Qual Life Outcomes. 2015 May 14;13:57. doi: 10.1186/s12955-015-0241-5.

Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Few studies have focused on the quality of life (QoL) associated medical costs for COPD in China.

METHODS

A cross-sectional survey of 678 COPD patients was conducted in four major cities (Beijing, Shanghai, Guangzhou and Chengdu), China, in 2011. Data on socio-demographic information, health conditions and medical costs were collected through a face-to-face interview combined with medical record searching. The EuroQol (EQ-5D) health questionnaire was applied to assess the QoL of COPD patients.

RESULTS

Among 678 patients with COPD, nearly 40% had difficulties in mobility, usual activities and pain/discomfort, one third had various degrees of anxiety/depression, and one fifth had difficulties in self-care. The COPD patients had a median utility score of 0.768 and a median visual analog scale score of 70. The degree of difficulties in any dimensions significantly increased, and utility and health scores decreased with severity of the disease. Age, gender and disease severity were significantly associated with the quality of life after taking other covariates into consideration. Poorer QoL was a significant indicator of higher direct medical costs for COPD patients.

CONCLUSION

Impaired quality of life was significantly linked to increased medical costs for COPD patients and could be an important measure for policy- and decision-making in COPD care.

摘要

背景

慢性阻塞性肺疾病(COPD)是全球主要死因之一。在中国,很少有研究关注 COPD 相关医疗费用的生活质量(QoL)。

方法

2011 年在中国四个主要城市(北京、上海、广州和成都)进行了一项 COPD 患者的横断面调查。通过面对面访谈结合病历检索收集了社会人口统计学信息、健康状况和医疗费用数据。采用欧洲五维健康量表(EQ-5D)健康问卷评估 COPD 患者的 QoL。

结果

在 678 例 COPD 患者中,近 40%的患者在移动、日常活动和疼痛/不适方面存在困难,三分之一的患者有不同程度的焦虑/抑郁,五分之一的患者在自我护理方面存在困难。COPD 患者的平均效用评分为 0.768,平均视觉模拟评分(VAS)为 70。各维度的困难程度显著增加,随着疾病严重程度的增加,效用和健康评分降低。在考虑其他协变量后,年龄、性别和疾病严重程度与生活质量显著相关。生活质量较差是 COPD 患者医疗费用增加的一个显著指标。

结论

生活质量受损与 COPD 患者医疗费用的增加显著相关,可能是 COPD 护理政策和决策的重要衡量标准。

相似文献

1
Quality of life and its association with direct medical costs for COPD in urban China.
Health Qual Life Outcomes. 2015 May 14;13:57. doi: 10.1186/s12955-015-0241-5.
3
COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.
Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2629-2641. doi: 10.2147/COPD.S167476. eCollection 2018.
4
Quality of life and its associated factors for mild chronic obstructive pulmonary disease patients of urban community settings.
Ann Palliat Med. 2020 Jul;9(4):1420-1430. doi: 10.21037/apm-19-655. Epub 2020 Jul 14.
7
Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D.
Qual Life Res. 2015 Oct;24(10):2549-58. doi: 10.1007/s11136-015-0979-6. Epub 2015 Apr 5.
9
Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
Int J Chron Obstruct Pulmon Dis. 2017 Sep 11;12:2711-2721. doi: 10.2147/COPD.S143244. eCollection 2017.

引用本文的文献

2
Cost-Effectiveness of Umeclidinium/Vilanterol versus Salmeterol/Fluticasone in Elderly Patients with Chronic Obstructive Pulmonary Diseases in China.
Int J Chron Obstruct Pulmon Dis. 2022 Mar 22;17:609-619. doi: 10.2147/COPD.S350218. eCollection 2022.
3
A Systematic Literature Review of the Humanistic Burden of COPD.
Int J Chron Obstruct Pulmon Dis. 2021 May 10;16:1303-1314. doi: 10.2147/COPD.S296696. eCollection 2021.
4
Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China.
Int J Chron Obstruct Pulmon Dis. 2021 Feb 23;16:433-441. doi: 10.2147/COPD.S276476. eCollection 2021.
6
8
The effect of Tualang honey on the quality of life of patients with chronic obstructive pulmonary disease: A randomized controlled trial.
J Taibah Univ Med Sci. 2017 Jul 5;13(1):42-50. doi: 10.1016/j.jtumed.2017.05.014. eCollection 2018 Feb.
9
The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.
Qual Life Res. 2018 Nov;27(11):2799-2814. doi: 10.1007/s11136-018-1928-y. Epub 2018 Jul 6.

本文引用的文献

1
Health-related quality of life in chronic obstructive pulmonary disease patients in Korea.
Health Qual Life Outcomes. 2014 Apr 24;12:57. doi: 10.1186/1477-7525-12-57.
2
COPD management costs according to the frequency of COPD exacerbations in UK primary care.
Int J Chron Obstruct Pulmon Dis. 2014;9:65-73. doi: 10.2147/COPD.S54417. Epub 2014 Jan 9.
3
Optimizing chronic disease management mega-analysis: economic evaluation.
Ont Health Technol Assess Ser. 2013 Sep 1;13(13):1-148. eCollection 2013.
4
Pulmonary hypertension complicating interstitial lung disease and COPD.
Semin Respir Crit Care Med. 2013 Oct;34(5):600-19. doi: 10.1055/s-0033-1356548. Epub 2013 Sep 13.
5
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
Clinicoecon Outcomes Res. 2013 Jun 17;5:235-45. doi: 10.2147/CEOR.S34321. Print 2013.
8
Six-minute walk distance and dyspnoea scores to assess the course of COPD exacerbation in elderly patients.
Clin Respir J. 2013 Jul;7(3):261-7. doi: 10.1111/j.1752-699X.2012.00314.x. Epub 2012 Aug 24.
9
Comparison of health-related quality of life measures in chronic obstructive pulmonary disease.
Health Qual Life Outcomes. 2011 Apr 18;9:26. doi: 10.1186/1477-7525-9-26.
10
The European Union conference on chronic respiratory disease: purpose and conclusions.
Eur Respir J. 2011 Apr;37(4):738-42. doi: 10.1183/09031936.00020211.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验